Michael Burgess
Chief Tech/Sci/R&D Officer at TURNSTONE BIOLOGICS CORP.
Net worth: - $ as of 2024-04-29
Michael Burgess active positions
Companies | Position | Start | End |
---|---|---|---|
TURNSTONE BIOLOGICS CORP. | Director/Board Member | 2021-05-06 | - |
Chief Tech/Sci/R&D Officer | 2017-09-30 | - | |
The Royal College of Physicians | Corporate Officer/Principal | - | - |
The Royal College of Paediatrics & Child Health | Corporate Officer/Principal | - | - |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Director/Board Member | 2022-07-19 | - |
Career history of Michael Burgess
Former positions of Michael Burgess
Companies | Position | Start | End |
---|---|---|---|
SYNLOGIC, INC. | Director/Board Member | 2019-12-31 | 2024-03-19 |
Independent Dir/Board Member | 2019-12-31 | 2024-03-19 | |
SPRINGWORKS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-05-09 | 2022-09-15 |
Roche Holding (UK) Ltd.
Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK. | Corporate Officer/Principal | 2009-12-31 | 2009-12-31 |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 2009-12-31 | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2013-01-16 | - |
░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Michael Burgess
University of Bristol | Doctorate Degree |
Statistics
International
United States | 6 |
United Kingdom | 5 |
Switzerland | 2 |
Operational
Corporate Officer/Principal | 7 |
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoral
Health Technology | 8 |
Consumer Services | 4 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
ROCHE HOLDING AG | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
SYNLOGIC, INC. | Health Technology |
SPRINGWORKS THERAPEUTICS, INC. | Health Technology |
Private companies | 5 |
---|---|
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Finance |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Roche Holding (UK) Ltd.
Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK. | Health Technology |
Turnstone Biologics Corp. | |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Health Technology |
- Stock Market
- Insiders
- Michael Burgess
- Experience